Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Piantelli

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
International Journal of Cancer|April 15, 1994
Quercetin enhances transforming growth factor beta 1 secretion by human ovarian cancer cellsG Scambia, P B Panici, F O Ranelletti, et al.
British Journal of Haematology|August 1, 1990
Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoidsL M Larocca, M Piantelli, G Leone, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sitesG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Leukemia Research|January 1, 1992
The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growthL Teofili, L Pierelli, M S Iovino, et al.
International Journal of Cancer|February 1, 1992
Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumorsF O Ranelletti, R Ricci, L M Larocca, et al.
International Journal of Cancer|February 1, 2000
Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumorsF O Ranelletti, N Maggiano, F G Serra, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible targetG Scambia, F O Ranelletti, P B Panici, et al.
Gynecologic Oncology|April 1, 1992
Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum (II)G Scambia, F O Ranelletti, P Benedetti Panici, et al.
Anti-Cancer Drug Design|September 1, 1995
Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure-activity relationshipsR De Vincenzo, G Scambia, P Benedetti Panici, et al.
British Journal of Cancer|December 1, 1990
Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cellsG Scambia, F O Ranelletti, P B Panici, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|April 15, 1994
Quercetin enhances transforming growth factor beta 1 secretion by human ovarian cancer cellsG Scambia, P B Panici, F O Ranelletti, et al.
British Journal of Haematology|August 1, 1990
Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoidsL M Larocca, M Piantelli, G Leone, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sitesG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Leukemia Research|January 1, 1992
The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growthL Teofili, L Pierelli, M S Iovino, et al.
International Journal of Cancer|February 1, 1992
Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumorsF O Ranelletti, R Ricci, L M Larocca, et al.
International Journal of Cancer|February 1, 2000
Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumorsF O Ranelletti, N Maggiano, F G Serra, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible targetG Scambia, F O Ranelletti, P B Panici, et al.
Gynecologic Oncology|April 1, 1992
Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum (II)G Scambia, F O Ranelletti, P Benedetti Panici, et al.
Anti-Cancer Drug Design|September 1, 1995
Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure-activity relationshipsR De Vincenzo, G Scambia, P Benedetti Panici, et al.
British Journal of Cancer|December 1, 1990
Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cellsG Scambia, F O Ranelletti, P B Panici, et al.
Pageof 14